Sat, Dec 27, 2014, 7:49 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

  • hwmccusker hwmccusker Jan 17, 2013 5:30 PM Flag

    For all the good science, this is gang that can't shoot straight

    The Bottom Line: Under the terms of the settlement, ACT will pay $12.5 M to the investors, plus legal expenses, comprised of $2 M in cash, $4.5 M in restricted common stock and $6 M through the issuance of an 8% amortizing redeemable convertible debenture that matures 6/15. The Company and Investors have agreed to enter into a registration rights agreement, which will require the Company to register the shares of common stock into which the debentures are convertible with the SEC. Will this… resolution of litigation attract a broader shareholder base … I doubt it!!

    ACTC closed down at $0.0835, -2.68% or -$0.0023.

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes, it will attract a broader base of shareholders and more importantly it will now attract big pharma who before this would not want to take on a company entangled in so much litigation. The stock closed at .0835, up from 2 fridays ago as well as up from last friday too. I think this will ease the doubts of those who may have been thinking of investing but were not sure. MY OPINION.

 
ACTC
6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Rice Energy Inc.
NYSEFri, Dec 26, 2014 4:02 PM EST